Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 12

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 12
---
 apply to private companies.
We have elected to use this extended transition period under the JOBS Act until the earlier of the date we (i) are no longer an emerging
growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act.

We are also a “smaller
reporting company” as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer
an emerging growth company, which would allow us to take advantage of many of the same exemptions available to emerging growth companies,
including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced
disclosure obligations regarding executive compensation. We will be able to take advantage of the scaled disclosures available to smaller
reporting companies for so long as our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured
on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed
fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business
day of our second fiscal quarter.

<div align='center'>3</div>

Additional Information

For additional information related to our business and operations, please refer to the reports incorporated herein by reference, as described under the caption “Incorporation of Certain Documents by Reference” on page16 of this prospectus.

Corporate Information

Incannex Healthcare Inc. was
incorporated in Delaware in July 2023. On November 28, 2023, the redomiciliation of Incannex Healthcare Limited, an Australian corporation,
or Incannex Australia, was implemented under Australian law in accordance with the Scheme Implementation Deed, as amended and restated
on September 13, 2023, between Incannex Australia and the Company. As a result of the redomiciliation, Incannex Australia became a wholly-owned
subsidiary of Incannex Healthcare Inc.

Our principal office is located
at Suite 105, 8 Century Circuit Norwest, NSW 2153 Australia and our telephone number is +61 409 840 786. Our address on the Internet is
http://www.incannex.com. The reference to our website address does not constitute incorporation by reference of the information contained